121 related articles for article (PubMed ID: 37657861)
1. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites.
Di Giorgio E; Benetti R; Kerschbamer E; Xodo L; Brancolini C
Int Rev Cell Mol Biol; 2023; 380():97-148. PubMed ID: 37657861
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
[TBL] [Abstract][Full Text] [Related]
3. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
4. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
5. Mapping the evolving landscape of super-enhancers during cell differentiation.
Kai Y; Li BE; Zhu M; Li GY; Chen F; Han Y; Cha HJ; Orkin SH; Cai W; Huang J; Yuan GC
Genome Biol; 2021 Sep; 22(1):269. PubMed ID: 34526084
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
Ooi WF; Xing M; Xu C; Yao X; Ramlee MK; Lim MC; Cao F; Lim K; Babu D; Poon LF; Lin Suling J; Qamra A; Irwanto A; Qu Zhengzhong J; Nandi T; Lee-Lim AP; Chan YS; Tay ST; Lee MH; Davies JO; Wong WK; Soo KC; Chan WH; Ong HS; Chow P; Wong CY; Rha SY; Liu J; Hillmer AM; Hughes JR; Rozen S; Teh BT; Fullwood MJ; Li S; Tan P
Nat Commun; 2016 Sep; 7():12983. PubMed ID: 27677335
[TBL] [Abstract][Full Text] [Related]
7. Etiology of super-enhancer reprogramming and activation in cancer.
Zhou RW; Parsons RE
Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
[TBL] [Abstract][Full Text] [Related]
8. HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.
Di Giorgio E; Paluvai H; Dalla E; Ranzino L; Renzini A; Moresi V; Minisini M; Picco R; Brancolini C
Genome Biol; 2021 May; 22(1):129. PubMed ID: 33966634
[TBL] [Abstract][Full Text] [Related]
9. Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
Chen X; Ma Q; Shang Z; Niu Y
NPJ Precis Oncol; 2020 Nov; 4(1):31. PubMed ID: 33299103
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted regulation of enhancers in cancer.
Xiao Q; Xiao Y; Li LY; Chen MK; Wu M
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194839. PubMed ID: 35750313
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer.
Heyn H; Vidal E; Ferreira HJ; Vizoso M; Sayols S; Gomez A; Moran S; Boque-Sastre R; Guil S; Martinez-Cardus A; Lin CY; Royo R; Sanchez-Mut JV; Martinez R; Gut M; Torrents D; Orozco M; Gut I; Young RA; Esteller M
Genome Biol; 2016 Jan; 17():11. PubMed ID: 26813288
[TBL] [Abstract][Full Text] [Related]
12. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
[TBL] [Abstract][Full Text] [Related]
13. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
[TBL] [Abstract][Full Text] [Related]
14. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
[TBL] [Abstract][Full Text] [Related]
16. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice.
Adam RC; Yang H; Rockowitz S; Larsen SB; Nikolova M; Oristian DS; Polak L; Kadaja M; Asare A; Zheng D; Fuchs E
Nature; 2015 May; 521(7552):366-70. PubMed ID: 25799994
[TBL] [Abstract][Full Text] [Related]
17. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.
Ding Y; Zhang B; Payne JL; Song C; Ge Z; Gowda C; Iyer S; Dhanyamraju PK; Dorsam G; Reeves ME; Desai D; Huang S; Payne KJ; Yue F; Dovat S
Leukemia; 2019 Nov; 33(11):2720-2731. PubMed ID: 31073152
[TBL] [Abstract][Full Text] [Related]
18. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
[TBL] [Abstract][Full Text] [Related]
19. Progressing super-enhancer landscape during mammary differentiation controls tissue-specific gene regulation.
Lee HK; Willi M; Shin HY; Liu C; Hennighausen L
Nucleic Acids Res; 2018 Nov; 46(20):10796-10809. PubMed ID: 30285185
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]